MS-377

Known as: MS 377 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
012319992018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
(R)-(+)-1-(4-Chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone L-tartrate (MS-377) is a novel… (More)
Is this relevant?
2002
2002
MS-377 ((R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone L-tartrate) is a antipsychotic… (More)
Is this relevant?
2002
2002
Rationale: MS-377 [(R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl) piperazin-1-yl]methyl-2-pyrrolidinone L-tartate] is a novel… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2002
2002
The role of MS-377, a novel selective sigma1 ligand currently being developed for the treatment of schizophrenia, in modulating… (More)
  • figure 1
Is this relevant?
2001
2001
A novel selective sigma(1) receptor ligand, (R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone… (More)
Is this relevant?
2001
2001
Phencyclidine (PCP)-induced head-weaving is inhibited by a novel selective σ1-ligand, (R)-(+)-1-(4-chlorophenyl)-3-[4-(2… (More)
  • table 2
  • table 1
  • table 3
Is this relevant?
2000
2000
MS-377 ((R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]++ +methy l-2-pyrrolidinone L-tartrate) is a novel… (More)
Is this relevant?
2000
2000
MS-377 is a novel selective sigma(1) ligand, currently being developed for the treatment of schizophrenia. In the present study… (More)
Is this relevant?
2000
2000
To evaluate the antipsychotic property of a sigma(1) receptor ligand, (R)-(+)-1-(4-chlorophenyl)-3-¿4-(2-methoxyethyl)piperazin-1… (More)
Is this relevant?
1999
1999
Rationale: MS-377 ((R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone l-tartrate) was… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?